In Reply:
Publication
, Journal Article
Meropol, NJ; Castel, LD; Schulman, KA; Weinfurt, KP
Published in: Journal of Clinical Oncology
February 1, 2004
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
February 1, 2004
Volume
22
Issue
3
Start / End Page
572 / 573
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Meropol, N. J., Castel, L. D., Schulman, K. A., & Weinfurt, K. P. (2004). In Reply:. Journal of Clinical Oncology, 22(3), 572–573. https://doi.org/10.1200/jco.2004.99.273
Meropol, Neal J., Liana D. Castel, Kevin A. Schulman, and Kevin P. Weinfurt. “In Reply:.” Journal of Clinical Oncology 22, no. 3 (February 1, 2004): 572–73. https://doi.org/10.1200/jco.2004.99.273.
Meropol NJ, Castel LD, Schulman KA, Weinfurt KP. In Reply:. Journal of Clinical Oncology. 2004 Feb 1;22(3):572–3.
Meropol, Neal J., et al. “In Reply:.” Journal of Clinical Oncology, vol. 22, no. 3, American Society of Clinical Oncology (ASCO), Feb. 2004, pp. 572–73. Crossref, doi:10.1200/jco.2004.99.273.
Meropol NJ, Castel LD, Schulman KA, Weinfurt KP. In Reply:. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2004 Feb 1;22(3):572–573.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
February 1, 2004
Volume
22
Issue
3
Start / End Page
572 / 573
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences